Who is the CEO of Nyxoah S.A.?

The CEO of Nyxoah S.A. is Olivier Taelman.

What industry does Nyxoah S.A. belong to?

Nyxoah S.A. operates in the Medical - Instruments & Supplies industry within the Healthcare sector.

Where is Nyxoah S.A. headquartered?

Nyxoah S.A. is headquartered at Rue Edouard Belin 12, Mont-Saint-Guibert, 1435, BE.

What is the IPO date of Nyxoah S.A.?

Nyxoah S.A. went public on April 28, 2021.

How many employees does Nyxoah S.A. have?

Nyxoah S.A. has approximately 183 full-time employees.

Nyxoah S.A.

NYXH•NASDAQ

Healthcare

Medical - Instruments & Supplies

$7.58

$-0.21(-2.70%)

Nyxoah S.A. (NYXH) Company Profile & Overview

Explore Nyxoah S.A.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Nyxoah S.A. (NYXH) Company Profile & Overview

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

SectorHealthcare

IndustryMedical - Instruments & Supplies

CEOOlivier Taelman

Contact Information

https://www.nyxoah.com

32 1 022 23 55

Rue Edouard Belin 12, Mont-Saint-Guibert, 1435

Company Facts

183 Employees

IPO DateApr 28, 2021

CountryBE

Actively Trading

Frequently Asked Questions

;